Skip to main content
Equibles
SLP logo

SLP · Simulations Plus, Inc. · Metrics

Track SLP — free

Use SLP with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SLP.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$18.50 +0.00 (+0.00%) At close · Oct 5
Rebalance outlook locked
Market Cap
$374.16M
Shares
20.22M
Volume · Oct 5 625.31K Avg daily vol (3M) 296.96K

SLP metrics

102 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$18.50
Market cap
$374.16M

Price action

20 metrics
Price change (1W)
+0.1%
Price change (30D)
+0.1%
Price change (3M)
+0.8%
Price change (6M)
+48.5%
Price change (YTD)
+1.5%
Price change (1Y)
+15.5%
Trailing year
Price change (5Y)
—
52-week high
$20.84
52-week low
$11.36
Change from 52-week high
-11.2%
Change from 52-week low
+62.9%
Annualized volatility
46.6%
Annualized volatility (3M)
2.8%
Beta
0.9
RSI (14D)
65.1
Price vs SMA 50
+0.6%
Price vs SMA 200
+13.2%
Avg volume (3M)
296,963
Relative volume
2.1
Average dollar volume
$5.45M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
20.22M

Valuation

12 metrics
P / E (TTM)
46.3
Trailing earnings · reciprocal yield 2.2%
PEG ratio
—
EV / revenue
4.0×
reciprocal yield 25.3%
EV / EBITDA
18.9×
reciprocal yield 5.3%
EV / EBIT
28.2×
reciprocal yield 3.5%
P / sales
4.6×
reciprocal yield 21.9%
P / book
2.7
reciprocal yield 37.2%
FCF yield
6.6%
TTM · current market cap
Buyback yield
—
P / FCF
15.2
reciprocal yield 6.6%
P / operating cash flow
15.0
reciprocal yield 6.7%
Earnings yield
2.2%

Historical valuation

8 metrics
P / E historical average (3Y)
70.8×
reciprocal yield 1.4%
P / E historical average (5Y)
79.3×
reciprocal yield 1.3%
EV / revenue historical average (3Y)
4.1×
reciprocal yield 24.6%
EV / revenue historical average (5Y)
8.7×
reciprocal yield 11.5%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
68.6×
reciprocal yield 1.5%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
43.7×
reciprocal yield 2.3%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-09

Profitability

9 metrics
Gross margin
63.4%
Operating margin
14.0%
Trailing 12 months
Net margin
9.9%
Gross profit (TTM)
$52.01M
Operating profit (TTM)
$11.50M
Net income (TTM)
$8.11M
Trailing 12 months
Diluted EPS (TTM)
$0.40
FCF margin
29.9%
Effective tax rate
35.4%

Per share

11 metrics
Revenue per diluted share (TTM)
$4.08
Gross profit per diluted share (TTM)
$2.58
Operating profit per diluted share (TTM)
$0.57
EBITDA per diluted share (TTM)
$0.85
Net income per diluted share (TTM)
$0.40
Operating cash flow per diluted share (TTM)
$1.24
Free cash flow per diluted share (TTM)
$1.22
Capital expenditures per diluted share (TTM)
$0.02
R&D per diluted share (TTM)
$0.57
Stock compensation per diluted share (TTM)
$0.32
Book value per share
$6.20

Growth

11 metrics
Revenue growth YoY
+7.5%
Year over year
Net income growth YoY
-750.2%
Revenue (TTM)
$82.06M
Trailing 12 months
EPS growth YoY
-757.1%
Shares change YoY
+0.6%
Year over year · more shares
Revenue CAGR (3Y)
+13.7%
Revenue CAGR (5Y)
+13.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+0.6%
FCF CAGR (5Y)
+10.3%

Quality

14 metrics
Return on equity
5.8%
Return on assets
5.3%
Debt / equity
0.0
Current ratio
5.5
EBITDA (TTM)
$17.12M
Free cash flow (TTM)
$24.54M
Quick ratio
5.5
Interest coverage
—
Net debt / EBITDA
-2.9
Return on invested capital
8.3%
Trailing 12 months
Net cash
$49.99M
Latest balance sheet
Cash & equivalents
$35.32M
Total assets
$152.98M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$24.94M
Capital expenditures (TTM)
$403,000
R&D (TTM)
$11.53M
SG&A (TTM)
$17.67M
Stock compensation (TTM)
$6.42M
R&D / revenue
14.1%
Stock compensation / revenue
7.8%

Ownership (13F)

9 metrics
13F filers
169
13F filer change QoQ
+8
Institutional ownership
78.3%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
40.6%
Private-fund adviser ownership
37.7%
Active holders' share change QoQ
+0.2%
Holder tenure
9.9
Price vs estimated holder cost
-1.6%

Ownership (registered funds)

1 metrics
Index-fund ownership
11.5%

Short interest

3 metrics
Short interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—

Insider activity

2 metrics
Net insider buying (90D)
−$18,280
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1023459 CUSIP 829214105 13F (30d) 22 filings 22 filers Visit website Investor relations